Int J Arrhythm.  2018 Jun;19(2):63-81. 10.18501/arrhythmia.2018.007.

2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias: Part 2

• Kim JY
• Kim SH
• Kim YR
• Kim YN
• Kim J
• Kim TH
• Nam GB
• Roh SY
• Park KM
• Park HS
• Pak HN
• Bae EJ
• Oh S
• Yoon N
• Lee MY
• Cho Y
• Cho Y
• Jin ES
• Cha TJ
• Choi JI

• KMID: 2418773
• DOI: http://doi.org/10.18501/arrhythmia.2018.007

Abstract

The recommendations outlined constitute the first clinical practice guidelines of the Korean Heart Rhythm Society regarding catheter ablation of ventricular arrhythmias (VA). This is a guideline PART 2, which includes VA in the structurally normal heart, inherited primary arrhythmia syndromes, VA related to congenital heart disease, as well as VA and sudden cardiac death observed in specific populations. In the structurally normal heart, treatment is guided by the occurrence of symptoms or the frequency of arrhythmias that cause ventricular dysfunction over time. Catheter ablation can be recommended in patients in whom anti-arrhythmic medications are ineffective. The sites of origin of arrhythmic activity are known to be the outflow tract, fascicles, papillary muscle, or the annulus. Specific cardiac channelopathies include congenital long QT and Brugada syndrome. This guideline discusses the diagnostic criteria, risk stratification, and treatment of these syndromes. We have included recommendations for adult congenital heart disease. Moreover, we have discussed the management of VA occurring in specific populations such as in patients with psychiatric and neurological disorders, pregnant patients, those with obstructive sleep apnea or drug-related pro-arrhythmias, athletes, and elderly patients.

MeSH Terms

Adult
Aged
Arrhythmias, Cardiac*
Athletes
Brugada Syndrome
Catheter Ablation*
Catheters*
Channelopathies
Death, Sudden, Cardiac
Heart
Heart Defects, Congenital
Humans
Nervous System Diseases
Papillary Muscles
Sleep Apnea, Obstructive
Ventricular Dysfunction